ADAR1 Capital Management’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $785K | Sell |
18,070
-86,783
| -83% | -$3.77M | 0.12% | 92 |
|
|
2025
Q1 | $3.92M | Buy |
104,853
+63,579
| +154% | +$2.38M | 0.73% | 37 |
|
|
2024
Q4 | $1.87M | Sell |
41,274
-15,909
| -28% | -$721K | 0.37% | 48 |
|
|
2024
Q3 | $3.36M | Buy |
57,183
+16,308
| +40% | +$958K | 0.55% | 34 |
|
|
2024
Q2 | $1.61M | Buy |
40,875
+34,875
| +581% | +$1.37M | 0.3% | 46 |
|
|
2024
Q1 | $399K | Buy |
+6,000
| New | +$399K | 0.09% | 85 |
|